Monday, 28 September 2015 12:08

Expanded Warning About Compounded Or Repackaged Drugs Stored In Becton-Dickson Syringes

Rate this item
(0 votes)

The attention of the Agency has been drawn to the alert by FDA regarding compounded or repackaged drugs stored in Becton-Dickson (BD) general use syringes, 1ml, 3ml, 5ml, 10ml, 20ml and 30ml syringes. The alert was based on Becton-Dickson reports that an interaction on the rubber stopper in certain lots of these syringes can cause some drugs stored in these syringes to lose potency if filled and not used immediately. These syringes have been cleared as medical devices for general purpose fluid aspiration and injection only and not for use as closed container storage system for drug products as the suitability of these syringes for that purpose have not been established.

The drugs that have been reported by Becton-Dickson to be affected by the stoppers include fentanyl, rocuronium, neostigmine, morphine, midazolam, methadone, atropine, hydromorphone, cisatracurium and remifetanyl.

Action required from Prescriber/Patients

NAFDAC…….Safeguarding the health of the Nation.

Read 14192 times Last modified on Monday, 06 June 2016 14:38

ONLINE PORTALS

napams

Contact Us from Mon - Friday: 08:00-16:00 GMT+1

Write Us:

NAFDAC Corporate Headquarters,

Plot 2032, Olusegun, Obasanjo Way,

Zone 7, Wuse, Abuja, Nigeria

 

Lagos Operation Office:

Plot 1, Industrial Estate, Lagos- Oshodi Apapa Express Way, Isolo, Lagos, Nigeria

 

 

 

 

 

 

For Enquiries:

Call: +234(0)-1-4609750

Email:nafdac@nafdac.gov.ng

 

 

 

 

 

 

 

 

 

 

 

For Complaints:

Call: +234(0)909-763-0506

         +234(0)909-763-0507

Email:reforms@nafdac.gov.ng

Or Send Us a Complaint

 

 

 

 

 

 

 

 

 

Contact Other NAFDAC Offices Nationwide